c-Met/HGFR
c-Met/HGFR inhibitors target the Hepatocyte Growth Factor Receptor (c-Met), a tyrosine kinase involved in cellular processes such as growth, motility, and morphogenesis. c-Met signaling is implicated in cancer progression, metastasis, and resistance to therapies. Inhibiting c-Met can disrupt tumor growth and spread, making these inhibitors valuable in cancer research. At CymitQuimica, we offer c-Met/HGFR inhibitors to support your research in oncology, metastasis, and targeted cancer therapies.
Read more
SAR125844
CAS:1116743-46-4
SAR125844, a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK), for …
Formula:
C25H23FN8O2S2
Purity:
98.39%
Color and Shape:
Solid
Molecular weight:
550.63
Ref: TM-T5467
| 1mg | 35.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 116.00 € | ||
| 25mg | 227.00 € | ||
| 50mg | 364.00 € | ||
| 100mg | 588.00 € | ||
| 200mg | 833.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Tuesday 3 Jun 2025
Tyrosine kinase-IN-6
CAS:2377507-01-0
Tyrosine kinase-IN-6 is a potent inhibitor of RON splice variants, demonstrating significant anticancer and antineoplastic …
Formula:
C37H31F2N5O5S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
695.73
Ref: TM-T79612
| 25mg | 1,730.00 € | ||
| 50mg | 2,262.00 € | ||
| 100mg | 2,945.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025
Terevalefim
CAS:1070881-42-3
Terevalefim (ANG-3777) is an hepatocyte growth factor (HGF) mimetic. Terevalefim selectively activates the c-Met receptor.
Formula:
C9H8N2S
Purity:
99.53%
Color and Shape:
Solid
Molecular weight:
176.24
Ref: TM-T37596
| 1mg | 56.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 210.00 € | ||
| 25mg | 369.00 € | ||
| 50mg | 537.00 € | ||
| 100mg | 750.00 € | ||
| 500mg | 1,539.00 € | ||
| 1mL*10mM (DMSO) | 119.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025
MK-2461
CAS:917879-39-1
MK-2461 is a novel inhibitor that targets multiple proteins and competitively binds to ATP sites, …
Formula:
C24H25N5O5S
Purity:
95.41% - 99.53%
Color and Shape:
Solid
Molecular weight:
495.55
Ref: TM-T6094
| 1mg | 52.00 € | ||
| 5mg | 120.00 € | ||
| 10mg | 187.00 € | ||
| 25mg | 363.00 € | ||
| 50mg | 552.00 € | ||
| 100mg | 842.00 € | ||
| 200mg | 1,130.00 € | ||
| 1mL*10mM (DMSO) | 134.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025
Canlitinib
CAS:2222730-78-9
Canlitinib, a tyrosine kinase inhibitor, holds potential for cancer research.
Formula:
C33H31F2N3O7
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
619.61
Ref: TM-T78206
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Jun 2025
c-met-IN-1
CAS:2084836-84-8
c-met-IN-1 is a potent and selective c-Met inhibitor (IC50: 1.1 nM) with antitumor activity.
Formula:
C35H37FN6O5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
640.7
Ref: TM-T10653
| 25mg | 1,730.00 € | ||
| 50mg | 2,262.00 € | ||
| 100mg | 2,945.00 € |
Estimated delivery in United States, on Tuesday 17 Jun 2025
EGFR-IN-8
CAS:2407957-87-1
EGFR-IN-8, a dual inhibitor targeting both EGFR and c-Met, shows potential as a promising candidate …
Formula:
C32H23ClF3N7O4
Purity:
97.45%
Color and Shape:
Solid
Molecular weight:
662.02
Ref: TM-T11162
| 1mg | 75.00 € | ||
| 5mg | 169.00 € | ||
| 10mg | 271.00 € | ||
| 25mg | 449.00 € | ||
| 50mg | 615.00 € | ||
| 100mg | 843.00 € |
Estimated delivery in United States, on Tuesday 1 Jul 2025
c-Met-IN-2
CAS:1635406-73-3
c-Met-IN-2 is a selective and orally available c-Met inhibitor (IC50: 0.6 nM) with antitumor activity.
Formula:
C24H21FN10O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
484.49
Ref: TM-T10654
| 25mg | 2,157.00 € | ||
| 50mg | 2,832.00 € | ||
| 100mg | 3,800.00 € |
Estimated delivery in United States, on Tuesday 15 Jul 2025
KRC-00715
CAS:2079853-72-6
KRC-00715 is an orally effective inhibitor of c-Met, exhibiting high selectivity with an IC50 of …
Formula:
C25H25F3N8O3
Color and Shape:
Liquid
Molecular weight:
542.51
Ref: TM-T200380
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Jul 2025
c-Met-IN-26
CAS:1635406-97-1
c-Met-IN-26 (compound 1-170) is an effective inhibitor of c-Met, exhibiting an IC50 of 1.6 nM.
Formula:
C24H19F2N9
Color and Shape:
Liquid
Molecular weight:
471.46
Ref: TM-T201085
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Jul 2025
